Koninklijke Philips (PHG) Projected to Post Quarterly Earnings on Wednesday

Koninklijke Philips (NYSE:PHG) is expected to announce its earnings results before the market opens on Wednesday, February 19th. Analysts expect the company to announce earnings of $0.55 per share and revenue of $5.10 billion for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Koninklijke Philips Price Performance

Shares of NYSE:PHG opened at $27.97 on Wednesday. The stock has a market cap of $26.29 billion, a PE ratio of -66.58, a price-to-earnings-growth ratio of 0.90 and a beta of 0.77. The business’s fifty day moving average price is $26.05 and its two-hundred day moving average price is $28.19. Koninklijke Philips has a one year low of $19.55 and a one year high of $32.91. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.74 and a current ratio of 1.16.

Analyst Upgrades and Downgrades

Several research firms recently commented on PHG. StockNews.com lowered Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Thursday, November 14th. Jefferies Financial Group upgraded Koninklijke Philips from an “underperform” rating to a “hold” rating in a report on Tuesday, October 29th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.